European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.3% to 1,524.80 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company argenx (ARGX), which advanced 6.4% and 3.2% respectively. They were followed by internet advertising firm Criteo (CRTO) and internet browser company Opera (OPRA), which were up 2.9% and 2.8% respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and pharmaceutical company Novo Nordisk (NVO), which fell 2.9% and 2.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and petroleum refiner Equinor (EQNR), which were down 1.5% and 1% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which rose 4.7% and 2.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and utilities company National Grid (NGG), which increased 0.9% and 0.8% respectively.

The decliners from the UK and Ireland were led by biotech company Trinity Biotech (TRIB), which plummeted 81%, followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP), which lost 3.4%. Tobacco company British American Tobacco (BTI) and biopharmaceutical company Akari Therapeutics (AKTX) dropped 2.3% and 1.6% respectively.